Lack of Pharmacokinetic Interaction of Levetiracetam on Carbamazepine, Valproic Acid, Topiramate, and Lamotrigine in Children with Epilepsy
Authors:
Abstract
Summary: Purpose:To determine whether levetiracetam (LEV) affects plasma concentrations of carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.Methods:The potential for interaction of LEV with other antiepileptic drugs (AEDs) was assessed using plasma drug levels obtained in a randomized placebo‐controlled phase III trial of adjunctive LEV in children receiving one or two concomitant AEDs. Multiple plasma AED levels at baseline and during adjunctive treatment with LEV or placebo were compared by repeated measures analysis of covariance and mean concentration ratios (treatment/baseline) were estimated with their 90% confidence intervals (CI).Results:The study population included 187 children receiving any concomitant AED alone or in combination. The geometric mean concentrations at baseline and during LEV treatment were carbamazepine 8.4 μg/ml versus 8.1 μg/ml (coefficient of variation, CV = 30%; n = 35); valproic acid 83.8 versus 82.5 μg/ml (CV = 38%; n = 23); topiramate 7.3 versus 7.2 μg/ml (CV = 82%; n = 28); lamotrigine 8.2 versus 7.7 μg/ml (CV = 62%; n = 22). For each AED, the mean concentration ratios (LEV/baseline) and their 90% CIs showed that AED concentrations were unaffected by concomitant LEV administration. No differences were observed between LEV and placebo.Conclusions:LEV does not affect plasma concentrations of carbamazepine, valproic acid, topiramate, or lamotrigine in children with epilepsy.Keywords
This publication has 14 references indexed in Scilit:
- Placebo-controlled study of levetiracetam in idiopathic generalized epilepsyNeurology, 2007
- Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproateEpilepsy Research, 2007
- Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizuresNeurology, 2006
- Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: A pooled analysis of data from randomized clinical trialsEpilepsy Research, 2005
- Clinical Pharmacokinetics of LevetiracetamClinical Pharmacokinetics, 2004
- Pharmacokinetics and metabolism of 14 C-levetiracetam, a new antiepileptic agent, in healthy volunteersEuropean Journal of Clinical Pharmacology, 2003
- Therapeutic Drug Monitoring of the Newer Antiepileptic DrugsTherapeutic Drug Monitoring, 2003
- Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugsThe Lancet Neurology, 2003
- Absence of Pharmacokinetic Drug Interaction of Levetiracetam with Phenytoin in Patients with Epilepsy Determined by New TechniqueThe Journal of Clinical Pharmacology, 2000
- Serum Concentrations of Valproic AcidTherapeutic Drug Monitoring, 1985